Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATP13A3 |
| Upstream (Parents) |
|---|
| (<<) SUCLG2 → ATP13A3 |
| (<<) NCOA2 → ATP13A3 |
| (<<) EIF4EBP2 → ATP13A3 |
| (<<) DHX9 → ATP13A3 |
| (<<) PTP4A1 → ATP13A3 |
| Downstream (Children) |
|---|
| ATP13A3 → NTS (>>) |
| ATP13A3 → ZBED2 (>>) |
| ATP13A3 → MAP3K13 (>>) |
| ATP13A3 → C19orf6 (>>) |
| ATP13A3 → PYGO1 (>>) |
| ATP13A3 → SLC25A30 (>>) |
| ATP13A3 → CDC42EP4 (>>) |
| ATP13A3 → HES2 (>>) |
| ATP13A3 → SUCLG2 (>>) |
| ATP13A3 → GTF2A1 (>>) |
| ATP13A3 → WAS (>>) |
| ATP13A3 → MAPK14 (>>) |
| ATP13A3 → ZDHHC17 (>>) |
| ATP13A3 → HMGCS1 (>>) |
| ATP13A3 → EIF4EBP2 (>>) |
| ATP13A3 → SKP2 (>>) |
| ATP13A3 → DHX9 (>>) |
| ATP13A3 → EIF4G2 (>>) |
| ATP13A3 → C10orf28 (>>) |
| ATP13A3 → APLP2 (>>) |
| ATP13A3 → XPNPEP3 (>>) |
| ATP13A3 → MDM4 (>>) |
| ATP13A3 → MCL1 (>>) |
| ATP13A3 → COPA (>>) |
